VM

Vaishali Mahajan

Active Director Director DIN 09512725
DIN 09512725 First appointment Feb 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Vaishali Mahajan

Data last updated:

Vaishali Mahajan is a Director at Voopar Sciences Private Limited (since 2022). The company operates in Pharma. Voopar Sciences Private Limited reported revenue of ₹1.64 Cr (FY 2024).

DIN 09512725
Primary Designation Director
Industry Pharma
First Appointment 21 Feb 2022
Oldest Company Age 9 yrs
Largest company Voopar Sciences Private Limited · ₹1.64 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Voopar Sciences Private Limited U24304HR2017PTC071167
Director21 Feb 20222017₹1.64 Cr (FY 2024)Active

Board colleagues of Vaishali Mahajan

Directorship timeline

Open interactive timeline →
Voopar Sciences Private Limited
Premium access

Shareholding and investment profile for Vaishali Mahajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vaishali Mahajan

Vaishali Mahajan currently holds 1 directorship: Voopar Sciences Private Limited (Director, since 21 Feb 2022, revenue ₹1.64 Cr (FY 2024)).

Vaishali Mahajan was first appointed on 21 Feb 2022 as Director at Voopar Sciences Private Limited.

The current boards of Vaishali Mahajan's companies include Puneet Mahajan (Voopar Sciences Private Limited), Ritu Chawla (Voopar Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available